Literature DB >> 18256934

Pregnancy-associated liver disorders.

Iryna S Hepburn1, Robert R Schade.   

Abstract

Liver disorders associated with pregnancy include hyperemesis gravidarum (HG), intrahepatic cholestasis of pregnancy (ICP), preeclampsia, syndrome of hemolysis, elevated liver enzymes and low platelets (HELLP), and acute fatty liver of pregnancy (AFLP). These conditions are relatively common and unique to pregnancy and are more likely to occur at certain terms of gestation specific to each condition. They can be associated with significant maternal and fetal morbidity and mortality. Although managing such patients may be very challenging, spontaneous resolution of the disease occurs shortly after termination of the pregnancy, usually without hepatic sequellae. Early diagnosis and timely treatment is a key to therapeutic success. This article explores the clinical features, pathophysiology, and management of these disorders.

Entities:  

Mesh:

Year:  2008        PMID: 18256934     DOI: 10.1007/s10620-007-0167-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  172 in total

Review 1.  Predicting fetal outcome in intrahepatic cholestasis of pregnancy: is the bile acid level sufficient?

Authors:  Robert S Egerman; Caroline A Riely
Journal:  Hepatology       Date:  2004-08       Impact factor: 17.425

2.  Prediction of HELLP syndrome with assessment of maternal dual hepatic blood supply by using Doppler ultrasound.

Authors:  Ikuno Kawabata; Akihito Nakai; Toshiyuki Takeshita
Journal:  Arch Gynecol Obstet       Date:  2006-05-06       Impact factor: 2.344

3.  Potential role of trans-inhibition of the bile salt export pump by progesterone metabolites in the etiopathogenesis of intrahepatic cholestasis of pregnancy.

Authors:  Marta Vallejo; Oscar Briz; Maria A Serrano; Maria J Monte; Jose J G Marin
Journal:  J Hepatol       Date:  2005-11-07       Impact factor: 25.083

Review 4.  Liver disease in pregnancy.

Authors:  J L Wolf
Journal:  Med Clin North Am       Date:  1996-09       Impact factor: 5.456

5.  Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking.

Authors:  P H Dixon; N Weerasekera; K J Linton; O Donaldson; J Chambers; E Egginton; J Weaver; C Nelson-Piercy; M de Swiet; G Warnes; E Elias; C F Higgins; D G Johnston; M I McCarthy; C Williamson
Journal:  Hum Mol Genet       Date:  2000-05-01       Impact factor: 6.150

6.  Frequently asked questions: iodinated contrast agents.

Authors:  Michael A Bettmann
Journal:  Radiographics       Date:  2004-10       Impact factor: 5.333

Review 7.  Hyperemesis gravidarum.

Authors:  T L Abell; C A Riely
Journal:  Gastroenterol Clin North Am       Date:  1992-12       Impact factor: 3.806

8.  Serum concentrations of lipids and apolipoproteins in normal and hyperemetic pregnancies.

Authors:  Y Ustün; Y Engin-Ustün; F Dökmeci; F Söylemez
Journal:  J Matern Fetal Neonatal Med       Date:  2004-05

9.  Mirtazapine (Remergil) for treatment resistant hyperemesis gravidarum: rescue of a twin pregnancy.

Authors:  Anke Rohde; Joerg Dembinski; Christoph Dorn
Journal:  Arch Gynecol Obstet       Date:  2003-06-18       Impact factor: 2.344

Review 10.  Pneumomediastinum following esophageal rupture associated with hyperemesis gravidarum.

Authors:  Shan-Guang Liang; Fumiko Ooka; Akiko Santo; Manabu Kaibara
Journal:  J Obstet Gynaecol Res       Date:  2002-06       Impact factor: 1.730

View more
  13 in total

1.  Acute fatty liver of pregnancy: over six months follow-up study of twenty-five patients.

Authors:  Hao-Feng Xiong; Jing-Yuan Liu; Li-Min Guo; Xing-Wang Li
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

Review 2.  Review of a challenging clinical issue: Intrahepatic cholestasis of pregnancy.

Authors:  Sebiha Ozkan; Yasin Ceylan; Orhan Veli Ozkan; Sule Yildirim
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

3.  Recent trends in hepatic diseases during pregnancy in the United States, 2002-2010.

Authors:  Sascha R Ellington; Lisa Flowers; Jennifer K Legardy-Williams; Denise J Jamieson; Athena P Kourtis
Journal:  Am J Obstet Gynecol       Date:  2014-10-30       Impact factor: 8.661

4.  Unique Liver Disease of Pregnancy Requiring Anaesthesia Support: A Case with Severe Hyperemesis Gravidarum.

Authors:  Berrin Günaydın; Aykut Özek; Naciye Türk Özterlemez; Ayca Taş Tuna
Journal:  Turk J Anaesthesiol Reanim       Date:  2017-08-01

Review 5.  Liver disease in pregnancy.

Authors:  Noel M Lee; Carla W Brady
Journal:  World J Gastroenterol       Date:  2009-02-28       Impact factor: 5.742

6.  Impaired fetal adrenal function in intrahepatic cholestasis of pregnancy.

Authors:  Chunfang Wang; Xiaojun Chen; Shu-Feng Zhou; Xiaotian Li
Journal:  Med Sci Monit       Date:  2011-05

7.  Total serum bile acids or serum bile acid profile, or both, for the diagnosis of intrahepatic cholestasis of pregnancy.

Authors:  Cristina Manzotti; Giovanni Casazza; Tea Stimac; Dimitrinka Nikolova; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2019-07-05

8.  Feasibility of urinary microRNA profiling detection in intrahepatic cholestasis of pregnancy and its potential as a non-invasive biomarker.

Authors:  Li Ma; Xiao-Qing Zhang; Da-Xue Zhou; Yue Cui; Lin-Lin Deng; Ting Yang; Yong Shao; Min Ding
Journal:  Sci Rep       Date:  2016-08-18       Impact factor: 4.379

9.  Evaluation of FGF-19 and β-klotho as biomarkers in patients with intrahepatic cholestasis of pregnancy.

Authors:  Ahter Tanay Tayyar; Ahmet Tayyar; Sukran Kozali; Resul Karakus; Nadiye Koroglu; Ilkbal Temel Yuksel; Gonca Yetkin Yildirim; Ismail Dag; Mustafa Eroglu
Journal:  Arch Med Sci       Date:  2018-01-10       Impact factor: 3.318

Review 10.  Liver Disease During Pregnancy: A Challenging Clinical Issue.

Authors:  Ivana Mikolasevic; Tajana Filipec-Kanizaj; Ivan Jakopcic; Iva Majurec; Alemka Brncic-Fischer; Nikola Sobocan; Irena Hrstic; Tea Stimac; Davor Stimac; Sandra Milic
Journal:  Med Sci Monit       Date:  2018-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.